Suppr超能文献

快速检测耳念珠菌中与唑类药物相关的耐药性和与棘白菌素类药物相关的耐药性。

Rapid Detection of -Associated Azole Resistance and -Associated Echinocandin Resistance in Candida auris.

机构信息

Public Health Research Institute, New Jersey Medical School, Rutgers Biomedical and Health Sciences, Newark, New Jersey, USA.

Department of Clinical Laboratory, Beijing Key Laboratory for Mechanisms Research and Precision Diagnosis of Invasive Fungal Diseases (BZ0447), Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

出版信息

Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01811-18. Print 2019 Jan.

Abstract

is an emerging multidrug-resistant yeast that can cause serious invasive infections. The accurate and rapid assessment of antifungal resistance is important for effective patient management. A novel and highly accurate diagnostic platform was established for the rapid identification of mutations conferring azole resistance and mutations associated with echinocandin resistance in Using allele-specific molecular beacons and DNA melting curve analysis following asymmetric PCR, a duplex assay and a simplex HS1 assay were developed to identify the most prominent resistance-associated mutations (Y132F and K143R in ; S639F in HS1) within 2 h. Assays were validated by testing a panel of 94 clinical isolates in a blind manner. The molecular diagnostic results from the assays were 100% concordant with DNA sequencing results. This platform has the potential to overcome the deficiencies of existing susceptibility-based assays to identify azole- and/or echinocandin-resistant , and thus, it holds promise as a surrogate diagnostic method to direct antifungal therapy more effectively.

摘要

是一种新兴的多药耐药酵母,可导致严重的侵袭性感染。准确快速地评估抗真菌药物耐药性对于有效管理患者至关重要。本研究建立了一种新颖而高度准确的诊断平台,用于快速鉴定导致唑类耐药的 突变和棘白菌素类耐药相关的 突变。通过等位基因特异性分子信标和不对称 PCR 后的 DNA 熔解曲线分析,开发了一种双管 检测和单管 HS1 检测,以在 2 小时内鉴定最主要的耐药相关突变( 中的 Y132F 和 K143R; 中的 S639F)。通过以盲法方式测试 94 株临床分离株的检测对该方法进行了验证。检测的分子诊断结果与 DNA 测序结果完全一致。该平台有可能克服现有基于药敏试验的检测方法在鉴定唑类和/或棘白菌素类耐药 方面的不足,因此有望成为一种替代诊断方法,更有效地指导抗真菌治疗。

相似文献

1
Rapid Detection of -Associated Azole Resistance and -Associated Echinocandin Resistance in Candida auris.
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01811-18. Print 2019 Jan.
3
Spontaneous Mutational Frequency and Mutation Rates Vary by Echinocandin Agent against .
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01692-18. Print 2019 Jan.
5
Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
Antimicrob Agents Chemother. 2018 May 25;62(6). doi: 10.1128/AAC.00238-18. Print 2018 Jun.
6
Rapid Detection of FKS-Associated Echinocandin Resistance in Candida glabrata.
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6573-6577. doi: 10.1128/AAC.01574-16. Print 2016 Nov.
7
Delineation of the Direct Contribution of Candida auris Mutations to Clinical Triazole Resistance.
Microbiol Spectr. 2021 Dec 22;9(3):e0158521. doi: 10.1128/Spectrum.01585-21. Epub 2021 Dec 8.
8
Development and Validation of TaqMan Chemistry Probe-Based Rapid Assay for the Detection of Echinocandin-Resistance in Candida auris.
J Clin Microbiol. 2023 Apr 20;61(4):e0176722. doi: 10.1128/jcm.01767-22. Epub 2023 Mar 28.
9
Recent increase in frequency in the SENTRY surveillance program: antifungal activity and genotypic characterization.
Antimicrob Agents Chemother. 2024 Oct 8;68(10):e0057024. doi: 10.1128/aac.00570-24. Epub 2024 Sep 12.
10
Evolutionary accumulation of 1 mutations from clinical echinocandin-resistant .
Emerg Microbes Infect. 2024 Dec;13(1):2377584. doi: 10.1080/22221751.2024.2377584. Epub 2024 Jul 22.

引用本文的文献

2
Integrating Clinical and Microbiological Expertise to Improve Vaginal Candidiasis Management.
Mycopathologia. 2024 Nov 8;189(6):96. doi: 10.1007/s11046-024-00904-8.
4
Development of a high-resolution melt-based assay to rapidly detect the azole-resistant isolates.
Curr Med Mycol. 2023 Sep;9(3):23-32. doi: 10.22034/CMM.2023.345114.1453.
5
Development and Validation of TaqMan Chemistry Probe-Based Rapid Assay for the Detection of Echinocandin-Resistance in Candida auris.
J Clin Microbiol. 2023 Apr 20;61(4):e0176722. doi: 10.1128/jcm.01767-22. Epub 2023 Mar 28.
7
: A Mini Review on Epidemiology in Healthcare Facilities in Asia.
J Fungi (Basel). 2022 Oct 26;8(11):1126. doi: 10.3390/jof8111126.
10
A Portable Droplet Magnetofluidic Device for Point-of-Care Detection of Multidrug-Resistant .
Front Bioeng Biotechnol. 2022 Mar 24;10:826694. doi: 10.3389/fbioe.2022.826694. eCollection 2022.

本文引用的文献

1
Candida auris: The recent emergence of a multidrug-resistant fungal pathogen.
Med Mycol. 2019 Jan 1;57(1):1-12. doi: 10.1093/mmy/myy054.
2
Limited Mutations Identified in Isolates of Candida auris Directly Contribute to Reduced Azole Susceptibility.
Antimicrob Agents Chemother. 2018 Sep 24;62(10). doi: 10.1128/AAC.01427-18. Print 2018 Oct.
3
Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
Antimicrob Agents Chemother. 2018 May 25;62(6). doi: 10.1128/AAC.00238-18. Print 2018 Jun.
5
Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris.
Diagn Microbiol Infect Dis. 2018 Mar;90(3):196-197. doi: 10.1016/j.diagmicrobio.2017.10.021. Epub 2017 Nov 7.
6
Candida auris: a Review of the Literature.
Clin Microbiol Rev. 2017 Nov 15;31(1). doi: 10.1128/CMR.00029-17. Print 2018 Jan.
7
Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally.
PLoS Pathog. 2017 May 18;13(5):e1006290. doi: 10.1371/journal.ppat.1006290. eCollection 2017 May.
10
Multidrug-resistant Candida auris: 'new kid on the block' in hospital-associated infections?
J Hosp Infect. 2016 Nov;94(3):209-212. doi: 10.1016/j.jhin.2016.08.004. Epub 2016 Aug 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验